CDC updates guidance on hepatitis B vaccination for infants born to virus-negative mothers

Jim O’Neil, Acting director of the Centers for Disease Control and Prevention (CDC)
Jim O’Neil, Acting director of the Centers for Disease Control and Prevention (CDC) - Official Website
0Comments

The Centers for Disease Control and Prevention (CDC) has announced a change in its approach to hepatitis B immunization for infants born to women who test negative for the hepatitis B virus. Under the new policy, the decision about whether to administer the hepatitis B vaccine, including the birth dose, will be based on individual considerations made by parents and health care providers.

This approach, known as shared clinical decision-making, encourages parents and medical professionals to weigh vaccine benefits, potential risks, and infection risks before deciding when or if a child should begin the hepatitis B vaccine series. Parents are advised to consult with their health care provider and consider factors such as whether any household members have hepatitis B or if there is frequent contact with individuals from regions where hepatitis B is more common.

If parents choose not to give their infant the birth dose of the vaccine, it is recommended that the first dose be given no earlier than two months of age.

The CDC’s Advisory Committee on Immunization Practices (ACIP) recently recommended these changes. The updated immunization schedule was approved by Jim O’Neill, Acting Director of the CDC and Deputy Secretary of Health and Human Services. Clinical guidance for hepatitis B vaccination will also be revised accordingly.

“This recommendation reflects ACIP’s rigorous review of the available evidence,” said Jim O’Neill. “We are restoring the balance of informed consent to parents whose newborns face little risk of contracting hepatitis B.”

The CDC is also considering ACIP’s suggestion that parents discuss serology testing with their health care provider to determine if additional doses of the vaccine are necessary. There are no changes for infants born to mothers who test positive for hepatitis B or whose status is unknown; they should continue receiving both the birth dose of hepatitis B vaccine and immunoglobulin as previously recommended.

The CDC noted that this shift maintains coverage across all payment methods, including programs such as Vaccines for Children Program, Children’s Health Insurance Program, Medicaid, Medicare, and insurance plans offered through the federal Health Insurance Marketplace.

The CDC continues its role in protecting public health by providing timely information and responding quickly to disease outbreaks in communities across the country. The agency supports scientific research and data innovation aimed at improving community health nationwide.



Related

Jim O’Neil, Acting director of the Centers for Disease Control and Prevention (CDC)

CDC updates childhood immunization schedule after review of international best practices

Deputy Secretary of Health and Human Services Jim O’Neill, currently serving as Acting Director of the Centers for Disease Control and Prevention (CDC), has signed a decision memorandum to update the U.S. childhood immunization schedule.

Jim O’Neill, Director

CDC investigates multistate Salmonella outbreak linked to raw oysters

Sixty-four people in 22 states have been infected with the same strain of Salmonella, according to a notice from the Centers for Disease Control and Prevention (CDC).

Jim O’Neil, Acting director of the Centers for Disease Control and Prevention (CDC)

Ralph Abraham sworn in as principal deputy director of CDC

Ralph Abraham, M.D., has been sworn in as Principal Deputy Director of the Centers for Disease Control and Prevention (CDC).

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Dekalb Business Daily.